These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

211 related articles for article (PubMed ID: 28991564)

  • 1. Imaging and Screening of Ovarian Cancer.
    Lowry KP; Lee SI
    Radiol Clin North Am; 2017 Nov; 55(6):1251-1259. PubMed ID: 28991564
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of transvaginal ultrasound in screening for ovarian cancer.
    Campbell S; Gentry-Maharaj A
    Climacteric; 2018 Jun; 21(3):221-226. PubMed ID: 29490504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Population screening and early detection of ovarian cancer in asymptomatic women.
    Nelson AE; Francis JE; Zorbas H;
    Aust N Z J Obstet Gynaecol; 2009 Oct; 49(5):448-50. PubMed ID: 19780723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ovarian status in healthy postmenopausal women.
    Healy DL; Bell R; Robertson DM; Jobling T; Oehler MK; Edwards A; Shekleton P; Oldham J; Piessens S; Teoh M; Mamers P; Taylor N; Walker F
    Menopause; 2008; 15(6):1109-14. PubMed ID: 18536617
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.
    Buys SS; Partridge E; Greene MH; Prorok PC; Reding D; Riley TL; Hartge P; Fagerstrom RM; Ragard LR; Chia D; Izmirlian G; Fouad M; Johnson CC; Gohagan JK;
    Am J Obstet Gynecol; 2005 Nov; 193(5):1630-9. PubMed ID: 16260202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ovarian cancer screening.
    van Nagell JR; Pavlik EJ
    Clin Obstet Gynecol; 2012 Mar; 55(1):43-51. PubMed ID: 22343228
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CA125 and transvaginal ultrasound monitoring in high-risk women cannot prevent the diagnosis of advanced ovarian cancer.
    Olivier RI; Lubsen-Brandsma MA; Verhoef S; van Beurden M
    Gynecol Oncol; 2006 Jan; 100(1):20-6. PubMed ID: 16188302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ovarian cancer screening.
    van Nagell JR; Gallion HH; Pavlik EJ; DePriest PD
    Cancer; 1995 Nov; 76(10 Suppl):2086-91. PubMed ID: 8635005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ACR Appropriateness Criteria
    ; Pandharipande PV; Lowry KP; Reinhold C; Atri M; Benson CB; Bhosale PR; Green ED; Kang SK; Lakhman Y; Maturen KE; Nicola R; Salazar GM; Shipp TD; Simpson L; Sussman BL; Uyeda J; Wall DJ; Whitcomb B; Zelop CM; Glanc P
    J Am Coll Radiol; 2017 Nov; 14(11S):S490-S499. PubMed ID: 29101987
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vignette-based study of ovarian cancer screening: do U.S. physicians report adhering to evidence-based recommendations?
    Baldwin LM; Trivers KF; Matthews B; Andrilla CH; Miller JW; Berry DL; Lishner DM; Goff BA
    Ann Intern Med; 2012 Feb; 156(3):182-94. PubMed ID: 22312138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Screening for familial ovarian cancer: failure of current protocols to detect ovarian cancer at an early stage according to the international Federation of gynecology and obstetrics system.
    Stirling D; Evans DG; Pichert G; Shenton A; Kirk EN; Rimmer S; Steel CM; Lawson S; Busby-Earle RM; Walker J; Lalloo FI; Eccles DM; Lucassen AM; Porteous ME
    J Clin Oncol; 2005 Aug; 23(24):5588-96. PubMed ID: 16110018
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ultrasound screening of ovarian cancer.
    Bäumler M; Gallant D; Druckmann R; Kuhn W
    Horm Mol Biol Clin Investig; 2019 Sep; 41(3):. PubMed ID: 31661436
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risks and benefits of screening asymptomatic women for ovarian cancer: a systematic review and meta-analysis.
    Reade CJ; Riva JJ; Busse JW; Goldsmith CH; Elit L
    Gynecol Oncol; 2013 Sep; 130(3):674-81. PubMed ID: 23822892
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ovarian cancer screening.
    Alexander-Sefre F; Menon U; Jacobs IJ
    Hosp Med; 2002 Apr; 63(4):210-3. PubMed ID: 11995270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ovarian cancer screening-ultrasound; impact on ovarian cancer mortality.
    Kamal R; Hamed S; Mansour S; Mounir Y; Abdel Sallam S
    Br J Radiol; 2018 Oct; 91(1090):20170571. PubMed ID: 30102555
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Role of Ca 125 in pelvic masses. Our experience].
    Rotondi M; Lauro C; Ammaturo FP; Guerriero V; Rasile M; Panariello S
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):51-4. PubMed ID: 11526720
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.
    Buys SS; Partridge E; Black A; Johnson CC; Lamerato L; Isaacs C; Reding DJ; Greenlee RT; Yokochi LA; Kessel B; Crawford ED; Church TR; Andriole GL; Weissfeld JL; Fouad MN; Chia D; O'Brien B; Ragard LR; Clapp JD; Rathmell JM; Riley TL; Hartge P; Pinsky PF; Zhu CS; Izmirlian G; Kramer BS; Miller AB; Xu JL; Prorok PC; Gohagan JK; Berg CD;
    JAMA; 2011 Jun; 305(22):2295-303. PubMed ID: 21642681
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Advances in the early detection of ovarian carcinoma.
    Garner EI
    J Reprod Med; 2005 Jun; 50(6):447-53. PubMed ID: 16050569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Update on ovarian cancer screening.
    Munkarah A; Chatterjee M; Tainsky MA
    Curr Opin Obstet Gynecol; 2007 Feb; 19(1):22-6. PubMed ID: 17218847
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Commentary on 'Performance of ultrasound as a second line test to serum CA125 in ovarian cancer screening'.
    Wan Y; Crosbie E
    BJOG; 2014 Dec; 121 Suppl 7():40-7. PubMed ID: 25488087
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.